• SENSEX 76,059.77
    -331.62 (--0.43%)
  • BANKNIFTY 56,693.50
    101.50 (+0.18%)
  • HCL Technologies
    1,275.50 1,770.00(%)
  • Shadowfax Technologies
    203.85 98.60(%)
  • Infosys
    1,014.15 984.00(%)
  • Bluestone Jewel
    793.45 872.60(%)
  • Bajaj Finance
    1,002.00 788.40(%)
  • HDFC Bank
    737.20 726.75(%)
  • Caliber Mining
    538.15 538.15(%)
  • E2E Networks
    516.95 516.95(%)
  • Coforge
    1,488.00 1,988.90(%)
  • ICICI Pru Life
    495.55 459.60(%)
  • SBI
    1,018.00 1,234.80(%)
  • AU Small Finance
    1,015.00 1,090.40(%)
  • SRF
    2,697.50 3,257.95(%)
  • Shriram Finance
    992.75 566.40(%)
  • Maruti Suzuki
    13,498.95 17,371.60(%)
  • B H E L
    418.00 446.75(%)
  • CG Power & Ind
    839.25 525.50(%)
  • Interglobe Aviat
    4,886.70 3,894.80(%)
  • Power Grid Corpn
    285.65 250.05(%)
  • Five-Star Bus.Fi
    537.45 733.70(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Lyka Labs Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 677.0
  • ISIN : INE933A01014
62.53 0 (-0.57%)
  • As on 25 Jul 2026 (EOD)

  • Today’s Low

    60.52

  • Today’s High

    63.99

  • Open

    60.52

  • Perv Close

    62.89

  • 52W Low

    44.10

  • 52W High

    121.44

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    226.06

  • Div & Yield %

    0.00

  • Book Value(₹)

    24.19

  • Debt-Equity Ratio

    -0.57

  • AGM Date

    24-Jul-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    1.14

  • Mar.Cap (₹Cr.)

    226.06

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    36.15

  • BV (₹)

    24.20

  • Sales( ₹ in Cr.)

    120.91

  • NP (in Cr.)

    -9.27

  • NP Var(%)

    -218.0

  • Div%

    0.0

  • CPS (₹)

    -0.20

  • EPS (₹)

    -2.60

  • Traded Value (₹ in Lakhs)

    229.82

  • 52 Week High

    121.44

  • 52 Week Low

    44.10

  • Price BSE

    64.0

  • Price NSE

    63.00

  • Market Capital( in Cr.)

    229.82

  • P/C Ratio

    -284.20

  • P/E Ratio

    -24.90

  • Price Vs.BV

    -2.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 120.91 134.70 106.40 80.59 164.35 62.26
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 120.91 134.70 106.40 80.59 164.35 62.26
Other Income 3.97 2.76 1.65 3.45 2.72 2.21
Stock Adjustments 1.08 1.37 0.79 1.21 0.40 -2.04
Total Income 125.96 138.83 108.84 85.25 167.47 62.43
EXPENDITURE :            
Raw Materials 46.57 54.60 43.73 30.27 31.27 21.48
Power and Fuel Cost 4.24 3.90 3.92 3.57 3.88 2.91
Employee Cost 41.60 34.40 26.01 17.48 16.22 13.03
Other Manufacturing Expenses 4.92 5.22 4.49 2.81 2.25 2.27
Selling and Administration Expenses 19.17 19.09 13.20 11.18 12.04 5.63
Miscellaneous Expenses 30.90 1.46 1.33 8.06 6.26 1.91
Employee Benefit Expenses 41.60 34.40 26.01 17.48 16.22 13.03
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 147.40 118.66 92.68 73.37 71.93 47.22
Operating Profit -21.45 20.17 16.15 11.88 95.55 15.20
Interest 3.33 2.30 4.80 11.57 19.92 25.55
Gross Profit -24.78 17.87 11.35 0.31 75.63 -10.35
Depreciation 8.46 6.77 12.29 13.52 15.39 8.05
Profit Before Tax -33.24 11.10 -0.94 -13.21 60.24 -18.40
Current Tax 0.83 2.73 1.60 0.21 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -1.77 0.46 -0.26 -0.13 20.34 -3.94
Reported Net Profit -32.29 7.92 -2.27 -13.29 39.90 -14.46
Extraordinary Items -23.01 0.03 0.04 -7.06 -3.09 -1.43
Adjusted Net Profit -9.28 7.89 -2.31 -6.23 42.99 -13.03
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -112.42 -120.33 -101.38 -88.09 -127.99 -113.54
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -144.70 -112.42 -103.65 -101.38 -88.09 -127.99
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -9.05 2.22 -0.69 -4.33 13.91 -5.04
Earnings Per Share(Adj)-Unit Curr -9.05 2.22 -0.69 -4.33 13.91 -5.04
Book Value 24.38 34.07 27.28 19.22 15.49 1.54
Book Value(Adj)-Unit Curr 24.38 34.07 27.28 19.22 15.49 1.54

Shareholding Pattern

  • Promoter Group

    58.45%

  • Public Share Holding

    41.55%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 15,745,631 43.55 15,745,631 4
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,386,586 14.90 5,386,586 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 21,132,217 58.45 21,132,217 14
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 713 0.00 50 5
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 60,490 0.17 60,490 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 500 0.00 0 2
Insurance Companies 101,000 0.28 100,000 2
Mutual Funds / UTI 3,400 0.01 0 4
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 132,651 0.37 132,651 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 298,754 0.83 293,191 17
2] Non Institution
Bodies Corporate 1,588,522 4.39 1,583,010 166
Clearing Members 519,263 1.44 519,263 20
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 500 0.00 500 1
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 389,728 1.08 384,771 261
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 755,645 2.09 755,137 551
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,609,966 9.99 3,299,916 65
Individuals holding nominal share capital up to Rs. 1 lakh 7,663,022 21.20 7,327,674 28,261
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 230 0.00 0 1
Others 0 0.00 0 0
Sub Total 14,721,740 40.72 14,065,035 29,338
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 36,152,711 100.00 35,490,443 29,369

Company Background

Lyka Labs LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Lyka Labs Ltd
  • BSE Code : 677.0
  • ISIN : INE933A01014

  • Incorporation Year

    1976

  • Registered Office

    4801/B & 4802/A
    GIDC Industrial Estate, Ankleshwar,
    Gujarat-393002

  • Telephone

    91-02646-221422/220549

  • FAX

    91-02646-250692

  • Chairman

    Babulal Jain

  • Managing Director

    KUNAL NARENDRA GANDHI

  • Company Secretary

    Shailendra Kumar Agrawal

  • Auditor

    D Kothary & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Sharex Dynamic (India) Pvt Ltd
    C-101 247 Park ,
    L B S Marg ,Vikhroli West
    Mumbai - Mumbai - 400083

Lyka Labs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Lyka Labs 63.57 124.88 120.91 -7.12 0.00
Abbott India 28,003.45 7,217.19 6,929.05 38.34 43.78
Astrazeneca Phar 8,000.10 2,304.07 2,275.58 106.65 27.86
P & G Health Ltd 6,723.60 944.52 934.17 34.14 71.75
Glaxosmi. Pharma 2,513.25 3,932.76 3,790.20 42.08 58.17
Cipla 1,410.90 20,102.60 18,979.95 37.08 13.88
Amrutanjan Healt 510.50 469.50 451.82 25.49 21.89
Bliss GVS Pharma 463.55 773.53 729.81 50.77 12.51
Fermenta Biotec. 432.60 474.15 450.25 19.81 18.77
Guj. Themis Bio. 360.50 152.47 150.80 84.23 27.21
Ambalal Sarabhai 32.45 19.52 3.94 22.69 6.77